use of one or more selected from the group consisting of a compound of formula (i), a racemic-diastereomeric mixture and an optical isomer of said compound, and a pharmaceutically acceptable salt and prodrug thereof, method, pharmaceutical composition and treatment kit cachexia and commercial packaging

摘要

use of one or more selected from the group consisting of a compound of formula (i), a racemic-diastereomeric mixture and an optical isomer of said compound, and a pharmaceutically acceptable salt and prodrug thereof, method, pharmaceutical composition and kit for treatment of cachexia and commercial packaging. The present invention relates to the use of a compound of the present invention or a pharmaceutically acceptable salt thereof, or a pharmaceutical composition comprising the salt compound, for the manufacture of a medicament for treating cachexia. The invention also relates to a method for treating cachexia comprising administering the compound of the present invention or a pharmaceutical composition comprising it to a human or an animal. The invention further relates to the use of said compound, or a pharmaceutically acceptable salt thereof, or a pharmaceutical composition comprising the compound or salt, in combination with one or more second active agents. further, the invention relates to a pharmaceutical composition and a kit comprising the compound of the present invention or a pharmaceutically acceptable salt thereof for treating said disease.